Neoadjuvant Pembrolizumab Not Tied to More AEs in Oral Cavity SCC
No increased perioperative morbidity seen among patients with local regionally advanced oral cavity squamous cell carcinoma
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Oncology, ENT, Pharmacy, Surgery, Journal, Source Type: news
More News: Cancer & Oncology | Carcinoma | Neoadjuvant Therapy | Oral Cancer | Skin Cancer | Squamous Cell Carcinoma